United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Technology Industry News Why Alibaba’s 12.9% stock surge is reigniting investor interest in AI + cloud plays Alibaba stock soared 12.9% after its Q2 FY25 results. Find out what drove investor confidence—from AI cloud growth to Taobao Instant Commerce. byPallavi MadhirajuAugust 31, 2025